Authors
Loading...
High-affinity HERG blockade by cisapride explains QT prolongation risk; leaves open contributions of other channels in clinical settings.
Key points are not available for this paper at this time.
Rampe et al. (1997) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: